RWD153 Attributable Costs of Breast Cancer in Colombia: A Cost-of-Illness Study Based on Administrative Claims Databases
Gloria Esperanza Londoño Torres(Universidad Nacional de Colombia), Gustavo Buitrago Hurtado(Universidad Nacional de Colombia), JM Reyes Sanchez, N. Castaño Gamboa(Pfizer (United Kingdom))
Cited by 0
Related Papers
Use of healthcare resources in a cohort of rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs or tofacitinib
|Clinical Rheumatology|2020|9
PCN210 RESOURCE UTILIZATION AND COST FOR WOMEN WITH ADVANCED HR+/HER2- BREAST CANCER IN COLOMBIAN HEALTH CARE SETTINGS
|Value in Health|2019|6
Budget Impact Analysis of Anticoagulation Clinics in Patients with Atrial Fibrillation under Chronic Therapy with Oral Anticoagulants
|Journal of Primary Care & Community Health|2021|3